To explore the mechanism of Epimedium in the treatment of osteoporosis based on network pharmacology
DOI: 10.23977/medcm.2021.030209 | Downloads: 8 | Views: 972
Author(s)
Lei Zhang 1, Feng Yang 1
Affiliation(s)
1 Shaanxi University of Chinese Medicine
Corresponding Author
Feng YangABSTRACT
Objective To screen the target and signal pathway of Epimedium active components in the treatment of osteoporosis by using network pharmacology, and to provide more promising evidence for the treatment of osteoporosis. Methods TCMSP analysis platform was used to screen the information of active constituents and active constituents of traditional Chinese medicine.Uniprot database and Excel were used to find the gene names of the active components.The disease-related targets were collected from Genecards database and OMim DRUGBANK database, and the overlapping values between the three databases were deleted. The intersection of Chinese medicine target genes and disease target genes was obtained by Venny software, and the obtained common genes of Chinese medicine and disease were input into Cytoscape software to obtain the disease-Chinese medicine and target regulatory network. Then, String software and Cytoscape software were used to construct the protein interaction network for the common target of TCM and disease. Common target genes were enriched by GO and KEGG function analysis, and the common target pathway was constructed by Cytoscape software.Results Twenty-three active components and 72 common target genes of Epimedium for the treatment of osteoporosis were screened. Concluded that the mechanism may be related to the AGE of diabetes complications -RAGE signaling pathways (AGE-RAGEsignalingpathwayindiabetic complications) way of TNF signaling pathways (TNFsignalingpathway) cancer (Pathwaysincancer) signaling pathway HIF - 1 signalingpathway (HIF - 1) etc, and Bai Jie - 6 gene (IL - 6) RAC - alpha serine/threonine protein...Vascular endothelial growth factor (AKT1)...Tumor necrosis factor (TNF) cell tumor antigen p53(TP53) may play a key role.Conclusion Based on network pharmacology, the mechanism of action of Epimedium in the treatment of osteoporosis was discussed, which provided an effective basis for the treatment of the disease.
KEYWORDS
network pharmacology, Epimedium, Osteoporosis, Core target signaling pathwayCITE THIS PAPER
Lei Zhang, Feng Yang, To explore the mechanism of Epimedium in the treatment of osteoporosis based on network pharmacology. MEDS Chinese Medicine (2021) 3: 35-43. DOI: http://dx.doi.org/10.23977/medcm.2021.030209
REFERENCES
[1] Paintin J, Cooper C, Dennison E. [J]. BR J Hosp Med (Lond), 2018, 79 (5): 253-258 XIA Weibo, ZHANG Zhenlin, LIN Hua, et al.
[2] Wang Y, Wang Y, Wang Y, et al. The effect of osteohydrophobic pine on the pathogenesis of osteohydrophobic pine [J]. Chinese Journal of Osteoporosis, 2019, 25 (3): 281-309.
[3] Zhang Shifang, He Qiushuo, Wang Yizhou, Liu Limin, Wang Lei.Journal of Shaanxi University of Traditional Chinese Medicine, 2010, 33(06): 145-147. (In Chinese)
[4] GUO Baolin, PEI Likuan, XIAO Peigen.Taxonomic significance of flavonoids from Epimedium [J]. Acta Botanica Sinica, 2008(06): 874-885.
[5] HUANG T. Study on extraction and purification of Epimedium from Tangshenkang capsule [J]. Tianjin Pharmacy, 2017, 29(06): 25-28. (In Chinese with English abstract)
[6] Wang Jianzhong, Gao Hongyan, Wang Kunzheng, Zhou Rongxing, Li Xiaodong, Guo Jun, Lv Huicheng.Effects of Epimedium on the expression of OPG/RANKL mRNA in osteonecrosis of femoral head [J]. Journal of Southern Medical University, 2011, 31(10): 1714-1717.
[7] Chen Keming, Ge Baofeng, Ma Huiping, Liu Xingyan, Bai Menghai, Ma Liping, Lv Mingbo. Effects of icariin on osteogenic differentiation of bone marrow stromal stem cells cultured in vitro [J]. Chinese Journal of Osteoporosis, 2008(09): 642-645+632.
[8] Gao Xiaoming, Shi Jianping.Effects of Epimedium extract on bone mineral density and weight in ovariectomized rats [J]. Journal of Inner Mongolia Medical University, 2013, 35(06): 442-445.
[9] Liang Xuezhen, Xu Bo, Li Gang, Gai Shuaishuai, Yan Bozhao, Li Jiacheng, Xia Congmin.Study on the mechanism of Bushenhuoxue capsule against osteoporosis based on network pharmacology and bioinformation [J]. Chinese Journal of Osteoporosis, 2018, 24(06): 755-761.
[10] Mingbo Lv, Xingyan Liu, Baofeng Ge, Keming Chen, Menghai Bai.Effects of icariin on bone marrow induced osteoclasts and bone resorption in mice [J]. Chinese Journal of Osteoporosis, 2007(05): 315-319.
[11] Gao Mengying, Huang Huijuan, Xie Shuhong.Effects of olivin on osteoclast proliferation [J]. Chinese Journal of Osteoporosis, 2017, 23(07): 896-899.
[12] Zhou Y N. Expression of PI3K, AKT1, AKT2 and NF-κB in bone tissue of type 2 diabetic osteoporosis rats [D]. Hebei Medical University, 2012.
[13] Mukherjee A, Rotwein P. Comparison of osteoblast differentiation and mediated osteoclast development in AKT1-mediated osteoblast signaling. Mol Cell Biol. 2012; 32 (2): 490 - 500. Doi: 10.1128 / MCB. 06361-11
[14] Lee Kh, Kim H, Kim CH, et al. Identified genetic variants for brady-induced osteonecrosis in the jaw: A case study. J Genet Med. 2019; Published 2019 Nov 20. DOI: 10.1186/s12967-019-2129-3
[15] Dubrovsky AM, Lim MJ, Lane Ne. Osteoporosis in Rheumatic Diseases: Anti- Rheumatic Diseases and the Skeletons. Calcif Tissue Int. 2018; 102 (5): 607 - 618. Doi: 10.1007 / s00223-018-0401-9
[16] Xie W, Ji L, Zhao T, Gao P. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray. Med Sci Monit. 2015; 21: 1333-1344. Published 2015 May 9. DOI:10.12659/MSM.894111
[17] Chen Peng, Li Yang, Hu Weiwen, Li Jian, He Runze.TNF-α promotes RANKL-induced osteoclast formation in postmenopausal osteoporosis by activating NF-κB [J].Genomics and Applied Biology, 2019, 38(02): 960-965.
[18] Liu Chenyue. Study on the effect mechanism of mulberry leaves on DOP rats based on AGEs/RAGE/NOX4 /NF-κB and TRPV6 / CABP-28K /VDR pathway [D]: Beijing University of Chinese Medicine, 2018, 1-20. (In Chinese with English abstract)
[19] LV Kiesel, Annemarie Kohl. The Role of RANKL pathway in breast cancer [J]. J Cancer Res, 2016, 86 (1): 87-91.
[20] INDO Y, TAKESHITA S, ISHII KA, et al.Metabolic regulation of osteoclast differentiation and function.J Bone Miner Res, 2013, 28 (11): 2392-2399.
[21] Wang Mingliang, Yan Xiaolong, Tian Sisheng.A network pharmacological study of Erxian decoction in the prevention and treatment of osteoporosis [J]. Chinese Journal of Osteoporosis, 2020, 26(04): 570-577.
[22] Miyauchi Y, Sato Y, Kobayashi T, et al. Osteoclast induction by estrogen deficiency in postmenopausal osteoporosis.Proc Natl ACAD Sci U Sa, 2013, 110 (41): 16588-16573.
[23] Wang Y, Wang Y, Wang Y, et al. The HIF-1 signaling pathway is associated with postmenopausal osteoporosis [J]. Journal of Sichuan University (Medical Science), 2017, 48(06): 862-868.
Downloads: | 4189 |
---|---|
Visits: | 163845 |
Sponsors, Associates, and Links
-
MEDS Clinical Medicine
-
Journal of Neurobiology and Genetics
-
Medical Imaging and Nuclear Medicine
-
Bacterial Genetics and Ecology
-
Transactions on Cancer
-
Journal of Biophysics and Ecology
-
Journal of Animal Science and Veterinary
-
Academic Journal of Biochemistry and Molecular Biology
-
Transactions on Cell and Developmental Biology
-
Rehabilitation Engineering & Assistive Technology
-
Orthopaedics and Sports Medicine
-
Hematology and Stem Cell
-
Journal of Intelligent Informatics and Biomedical Engineering
-
MEDS Basic Medicine
-
MEDS Stomatology
-
MEDS Public Health and Preventive Medicine
-
Journal of Enzyme Engineering
-
Advances in Industrial Pharmacy and Pharmaceutical Sciences
-
Bacteriology and Microbiology
-
Advances in Physiology and Pathophysiology
-
Journal of Vision and Ophthalmology
-
Frontiers of Obstetrics and Gynecology
-
Digestive Disease and Diabetes
-
Advances in Immunology and Vaccines
-
Nanomedicine and Drug Delivery
-
Cardiology and Vascular System
-
Pediatrics and Child Health
-
Journal of Reproductive Medicine and Contraception
-
Journal of Respiratory and Lung Disease
-
Journal of Bioinformatics and Biomedicine